PROGEN PHARMACEUTICALS INC has a total of 11 patent applications. Its first patent ever was published in 2001. It filed its patents most often in Australia, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are DOMPE PHA R MA SPA RES & MFG, KOZIKOWSKI ALAN P and DOMPE FA R MA S P A.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 5 | |
#2 | United States | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Acyclic or carbocyclic compounds | |
#3 | Medical preparations | |
#4 | Heterocyclic compounds | |
#5 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Marton Laurence J | 10 |
#2 | Frydman Benjamin | 7 |
#3 | Blokhin Andrei V | 7 |
#4 | Basu Hirak S | 7 |
#5 | Valasinas Aldonia L | 6 |
#6 | Reddy Venodhar K | 5 |
#7 | Clifford Linda | 2 |
#8 | Valasinas Aldonia | 2 |
#9 | Reddy Venudhar K | 1 |
#10 | Wang Yu | 1 |
Publication | Filing date | Title |
---|---|---|
WO2011097317A1 | Use of n1,n4-bis[3-(ethylamino)propyl]-2-butene-1,4-diamine compounds in combination with epigenetic-acting pharmaceuticals for enhanced cancer therapy | |
WO2008112251A1 | Cyclopropyl-containing polyamine analogs as disease therapies | |
AU2005201724A1 | Novel polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases |